AbCellera Biologics (ABCL) Amortizatization of Intangibles (2020 - 2025)
AbCellera Biologics' Amortizatization of Intangibles history spans 6 years, with the latest figure at $941000.0 for Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 101.53% year-over-year to $941000.0, compared with a TTM value of $3.7 million through Dec 2025, down 39.31%, and an annual FY2025 reading of $3.7 million, down 39.31% over the prior year.
- Amortizatization of Intangibles for Q4 2025 was $941000.0 at AbCellera Biologics, roughly flat from $940000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $64.4 million in Q3 2024, with the low at -$61.7 million in Q4 2024.
- Average Amortizatization of Intangibles over 5 years is $2.5 million, with a median of $1.1 million recorded in 2022.
- Biggest YoY gain for Amortizatization of Intangibles was 16700.77% in 2024; the steepest drop was 1019.37% in 2024.
- Tracing ABCL's Amortizatization of Intangibles over 5 years: stood at $8.2 million in 2021, then skyrocketed by 35.25% to $11.0 million in 2022, then crashed by 39.24% to $6.7 million in 2023, then crashed by 1019.37% to -$61.7 million in 2024, then surged by 101.53% to $941000.0 in 2025.
- Per Business Quant, the three most recent readings for ABCL's Amortizatization of Intangibles are $941000.0 (Q4 2025), $940000.0 (Q3 2025), and $929000.0 (Q2 2025).